Oncogenesis

Papers
(The H4-Index of Oncogenesis is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer75
CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils70
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia60
Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis60
Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance57
Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle56
BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling55
TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple53
Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA51
Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation51
Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges48
Targeting PD-L1 in non-small cell lung cancer using CAR T cells48
Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway48
TGF-β1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor47
miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities46
ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis43
Suppressing DRP1-mediated mitochondrial fission and mitophagy increases mitochondrial apoptosis of hepatocellular carcinoma cells in the setting of hypoxia42
Tumor-derived HMGB1 induces CD62Ldim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer41
COX6B2 drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells38
Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance38
LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival37
PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas37
Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts36
lncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM236
Overexpression of Cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors35
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells31
USP29-mediated HIF1α stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis30
Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation30
Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming30
0.036361932754517